Study details
Enrolling now
A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers
Applied Biologics, LLC
NCT IDNCT07159282ClinicalTrials.gov data as of Apr 2026
Phase
Phase 4
Target enrollment
60
Study length
about 2 years
Ages
18+
Locations
1 site in FL
About this study
This trial is testing whether a single layer placental-based allograft (XWRAP) helps heal nonhealing diabetic foot ulcers compared to standard care. Patients with nonhealing diabetic foot ulcers who are enrolled in another trial may be eligible for this trial if they don't improve with the other treatment.
Based on ClinicalTrials.gov records.
What participants do
- 1.XWRAP
PhasePhase 4
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low11%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Endpoints
Secondary: Adverse Events, Pain, Enjoyment of Life, and General Activity Scale, Time to Closure, Wound Quality of Life
Body systems
Endocrinology